The study will involve 96 women with cervix cancer and those at high risk of developing the disease. Patients with metastatic disease or those who are younger than 18 years of age will not be included in the study. The patients will be assessed on their values and attitudes toward their health and the risks of undergoing a complex treatment. A chance board will be shown to them where they will rate the chances of developing certain side effects from a particular treatment.
Researchers from the Manipal Teaching Hospital in Pokhara, Nepal studied 159 women with cervix cancer between 2000 and 2008. The researchers used theoretical statistics and curve fitting to validate various growth models. The cubic model demonstrated the best fit. The researchers also aimed to determine if there is a link between chemotherapy and radiotherapy and stage progression. The results of the study are promising. Patients with cervix cancer are more likely to survive if they have access to modern treatments.
Treatment options for cervix cancer vary, depending on the stage and location of the disease. Some patients may only need surgery while others may undergo radiation therapy or chemotherapy. Treatment options for recurrent cervical cancer depend on the type of treatment that is most appropriate for each individual patient. The most common treatment options include chemotherapy and surgery. The duration of treatment depends on the stage and location of the disease. Some patients may not respond to chemotherapy, and instead require radiation therapy and chemotherapy to reduce tumor growth and improve quality of life.
Cervix cancer is a common disease in Indonesia and is highly preventable. The strongest risk factor for this cancer is the Human Papilloma Virus. While the causes of cervix cancer are unclear, research-based studies are pointing to a strong connection. For women at high risk, the disease will affect them as well. But prevention is still the best course of action. And it is possible to cure cervix cancer if detected at an early stage.
Radiation therapy for cervical cancer can lead to relapses in some women. This is due to the fact that some cancer cells survived the treatment and remain undetectable outside the pelvis. These microscopic areas of cancer are known as micrometastases, and they can cause a relapse after radiation therapy. It is important to seek medical attention for this type of cancer as it can be very debilitating for a woman’s reproductive system.
The study used 526 complete twin pairs. Of these, 348 were concordant with no abnormalities, while 18 were discordant. The results of these tests were not different between MZ and DZ twin pairs. This suggests that genetic factors may play a role in individual differences in vulnerability to cervix cancer. There are no differences between sisters and twins when it comes to the prevalence of cervix cancer.
